Cue Biopharma Inc. (CUE) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cue Biopharma Inc.

    NASDAQ: CUE · Real-Time Price · USD
    0.71
    0.02 (2.88%)
    At close: Sep 26, 2025, 3:57 PM
    0.70
    -1.99%
    After-hours: Sep 26, 2025, 07:29 PM EDT

    Cue Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 22.46M 48.51M 51.61M 64.37M
    Short-Term Investments
    		 n/a n/a 24.67M n/a
    Long-Term Investments
    		 152K 151K 150K 150K
    Other Long-Term Assets
    		 2.06M 2.81M 3.24M 2.86M
    Receivables
    		 945K 1.7M 57.25K 3.14M
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 805K 1.24M 217.00 n/a
    Total Current Assets
    		 25.14M 51.45M 77.19M 68.47M
    Property-Plant & Equipment
    		 4.84M 7.12M 10.7M 11.92M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 7.05M 10.08M 14.1M 14.93M
    Total Assets
    		 32.19M 61.53M 91.28M 83.4M
    Account Payables
    		 2.82M 3.5M 2.73M 2.59M
    Deferred Revenue
    		 85K 2.11M n/a 645.35K
    Short-Term Debt
    		 4.33M 3.96M 1.96M 1.97M
    Other Current Liabilities
    		 n/a 1.92M 535.00 38.31K
    Total Current Liabilities
    		 13.69M 17.08M 11.55M 12.79M
    Long-Term Debt
    		 n/a 4.2M 8.04M n/a
    Other Long-Term Liabilities
    		 n/a n/a -658 n/a
    Total Long-Term Liabilities
    		 1M 7.36M 14.05M 5.12M
    Total Liabilities
    		 14.69M 24.45M 25.6M 17.91M
    Total Debt
    		 8.88M 14.7M 19.32M 10.05M
    Book Value
    		 17.5M 37.09M 65.68M 65.49M
    Book Value Per Share
    		 0.31 0.81 1.84 2.09
    Common Stock
    		 62K 47K 43.04K 32.2K
    Retained Earnings
    		 -341.86M -301.19M -250.46M -197.45M
    Comprehensive Income
    		 n/a n/a -95.87K n/a
    Shareholders Equity
    		 17.5M 37.09M 65.68M 65.49M
    Total Investments
    		 152K 151K 24.67M 150K

    Add to Watchlist